Renilla Luciferase Assay System Technical Manual, TM055
Renilla Luciferase Assay System Technical Manual, TM055
Renilla Luciferase Assay System Technical Manual, TM055
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Luminometers<br />
Product<br />
Turner Designs Model TD-20/20 Luminometer<br />
Turner Designs Model TD-20/20 Luminometer with Printer<br />
Turner Designs Model TD-20/20 Luminometer with Single Auto Injector<br />
Turner Designs Model TD-20/20 Luminometer with Dual Auto Injector<br />
Turner Designs Model TD-20/20 Luminometer with Printer<br />
and Dual Auto Injector<br />
Cat.#<br />
E2041<br />
E2051<br />
E2351<br />
E2361<br />
E2061<br />
(a) Patent Pending.<br />
(b) Certain applications of this product may require licenses from others.<br />
(c) U.S. Pat. No. 5,283,179, 5,641,641, 5,650,289, 5,814,471, Australian Pat. No. 649289 and European Pat. No. 0 553 234 have been issued to<br />
Promega Corporation for a firefly luciferase assay method, which affords greater light output with improved kinetics as compared to the conventional<br />
assay. Other patents are pending.<br />
(d) Licensed under U.S. Pat. Nos. 5,292,658, 5,418,155 and other patents.<br />
(e) The CMV promoter and its use are covered under U.S. Pat. Nos. 5,168,062 and 5,385,839 owned by the University of Iowa Research<br />
Foundation, Iowa City, Iowa, and licensed FOR RESEARCH USE ONLY. Commercial users must obtain a license to these patents directly from<br />
the University of Iowa Research Foundation.<br />
(f) U.S. Pat. No. 5,744,320 and Australian Pat. No. 721172 have been issued to Promega Corporation for quenching reagents and assays for<br />
enzyme-mediated luminescence. Other patents are pending.<br />
(g) The cationic lipid component of the TransFast Transfection Reagent is covered by U.S. Pat. Nos. 5,824,812, 5,869, 715 and pending foreign<br />
patents.<br />
(h) Transfectam is a registered trademark of BioSepra, S.A., the holder of a license from CNRS-ULP Strasbourg under U.S. Pat. No. 5,171,678 to<br />
sell the Transfectam ® product for research purposes only. The Transfectam ® product was developed by J.P. Behr and J.P. Loeffler and is covered<br />
by the aforementioned patent.<br />
(i) The cationic lipid component of the Tfx Reagents is covered by U.S. Pat. Nos. 5,527,928, 5,744,625 and 5,892,071, Australian Pat. No.<br />
704189 and other pending foreign patents.<br />
(j) Organizations may use this product in their research and they may transfer derivatives of the product to colleagues at other Nonprofit<br />
Organizations provided that such colleagues agree in writing to be bound by the terms and conditions of this label license. Researchers may<br />
not transfer this product or its derivatives to researchers at other organizations, which are not Nonprofit Organizations, without the express written<br />
consent of Promega and without those entities having an express license from Promega for the use of the product. Other than as specifically<br />
provided here, an authorized transferee of this product shall have no right to transfer this product or its derivatives to any other person or<br />
entity. A Nonprofit Organization means (1) a university or other institution of higher education located in any country; (2) an organization of the<br />
type described in section 501(c)(3) of the Internal Revenue Code of 1954 [26 U.S.C. 501(c)(3)] and exempt from taxation under section 501(a)<br />
of the Internal Revenue Code [26 U.S.C. 501(a)]; or (3) any nonprofit organization located in a foreign country that would qualify as a nonprofit<br />
organization under paragraph (2) of this section if it were located in the United States. Any organization that is not "Nonprofit" as defined here is<br />
considered a for-profit organization. A Nonprofit Organization performing research for a for-profit organization also shall be considered for-profit.<br />
With respect to research use by for-profit organizations, or any diagnostic or therapeutic uses, please contact Promega Corporation for supply<br />
and licensing information.<br />
© 2001 Promega Corporation. All Rights Reserved.<br />
Dual-<strong>Luciferase</strong> and ProFection are trademarks of Promega Corporation and are registered with the U.S. Patent and Trademark Office. Tfx and<br />
TransFast are trademarks of Promega Corporation.<br />
Triton is a registered trademark of Union Carbide Chemicals and Plastics Co., Inc.<br />
All prices and specifications are subject to change without prior notice.<br />
Product claims are subject to change. Please contact Promega <strong>Technical</strong> Services or access the Promega online catalog for the most up-todate<br />
information on Promega products.<br />
Promega Corporation · 2800 Woods Hollow Road · Madison, WI 53711-5399 USA · Toll Free in USA 800-356-9526 · Telephone 608-274-4330 · Fax 608-277-2516 · www.promega.com<br />
Printed in USA.<br />
Part# <strong>TM055</strong><br />
Revised 6/01 Page 13